ClinicalTrials.gg
CompletedNCT06529224Updated Oct 16, 2026

Social Egg Freezing: Will Health Professionals Offer it ?

An observational study in Infertility,Female, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

How we know

Updated Oct 16, 2026Now CompletedStart date moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,551
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 20 studies in Infertility, Female with a site in France — 5 open to participants now, 5 under way, 1 of them phase 3. Infertility, Female · France.

Enrollment
3rd of 11
1,551 · median 127
Started
2024
the only one that year
Observational
11 of 20
3 open now
Registered
14th of 20
by date
Lead sponsor
2 of 20
Centre Hospitalier Universitaire de Saint Etienne

Among the 20 studies in Infertility, Female with a site in France, this one is the 3rd largest by enrollment of the 11 observational ones that give a count, is the only one that started in 2024, is one of 11 observational ones, and was the 14th registered.

Infertility, Female

553 studies on the registry are indexed under Infertility, Female; 133 are open to participants now.

Browse Infertility, Female studies →

Open to participants now

5 of the 20 studies in Infertility, Female with a site in France are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 88 Infertility, Female studies recruiting now, 11 (13%) set no upper age limit and 77 (88%) stop at 75 or younger; 9 take children under 18; 29 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Infertility, Female with a site in France, or all of them as a file.
02

Study summary

In 2021, the revision of bioethics laws opened the door to elective egg freezing. This gives women, between their 29th and 37th birthdays, the opportunity to freeze their eggs in order to combat age decline fertility. However, communication about this new possibility has remained limited both toward women and their health professional.

Read the detailed description

Thus, the hypothesize of this study is that these professionals, namely physicians, gynecologists and midwives, are insufficiently aware of age-related fertility decline and unaware of the possibility of elective egg freezing.

This multicenter observational cross-sectional study whose objective will be:

  • To assess the knowledge of these professionals in terms of age-related fertility decline.
  • To measure their propensity to spontaneously broach the subject with their childless patients.
  • To assess their knowledge and support for elective egg freezing. This study will be done using an online questionnaire that will be distributed in electronic format to all the health professionals concerned in the participating areas.

This study will provide valuable knowledge on the perception of elective egg freezing by health professionals, determine their training needs and motivate new information campaigns on this subject.

03

Conditions studied

  • Infertility,Female

Browse trials for

Keywords

  • Elective egg freezing
  • Attitude of health professionals
  • Health knowledge
  • Aging
  • Female infertility
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Practising GPs, gynaecologists or midwives

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be a general practitioner, gynecologist or midwife in practice for at least one year
  • Follow patients between 29 and 37 years old (for their for example)

Exclusion criteria

Exclusion Criteria:

  • Have been practising for less than a year
  • Have no patients aged between 29 and 37
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,551 participants (actual)
Patient registry
No

Groups and cohorts

  • Health professionals

    General practitioner, gynecologist or midwife

    Other: Online questionnaire

Interventions

  • OtherOnline questionnaire

    An online questionnaire will be distributed in electronic format to all the healthcare professionals concerned.

06

What researchers measure

Primary outcomes

  1. Knowledge of primary care professionals regarding age-related decline in fertility.

    Analysis questionnaire results.

    Time frame: Day 1

  2. Propensity to spontaneously broach the subject with their patients without children.

    Analysis questionnaire results.

    Time frame: Day 1

  3. Knowledge and support for the elective egg freezing.

    Analysis questionnaire results.

    Time frame: Day 1

07

Study locations

1 site
  • CHU Saint Etienne
    Saint-Etienne, 42000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Apr 2024 to primary completion in Oct 2024, 6 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Feb 2025 → Oct 2024 and completion Feb 2025 → Oct 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2024
First posted
Jul 31, 2024
StartActual
Apr 5, 2024
Primary completionActual
Oct 30, 2024was Feb 2025
CompletionActual
Oct 30, 2024was Feb 2025
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 16, 2026
Sites
1 site added, 1 site removed
Show site
  • CHU Saint Etienne · Saint-Etienne, France
Show 1 removed
  • CHU Saint Etienne · Saint-Étienne, France
Oct 16, 2026
Start date
Apr 1, 2024→Apr 5, 2024
Oct 16, 2026
Primary completion
Feb 2025→Oct 30, 2024 (actual)
Oct 16, 2026
Study completion
Feb 2025→Oct 30, 2024 (actual)
Oct 16, 2026
Enrollment
2500 (estimated)→1551 (actual)
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • CHU Saint Etienne · Saint-Etienne, France
    Show 1 removed
    • CHU Saint Etienne · Saint-Étienne, France
    Start date Apr 1, 2024→Apr 5, 2024
    Primary completion Feb 2025→Oct 30, 2024 (now actual)
    Study completion Feb 2025→Oct 30, 2024 (now actual)
    Enrollment 2500 (estimated)→1551 (actual)
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06529224
Responsible party
Sponsor
First posted
Jul 31, 2024
Start date
Apr 5, 2024
Primary completion
Oct 30, 2024
Completion
Oct 30, 2024
Last update
Oct 16, 2026

Study contacts

Jean-Philippe KLEIN, MD
principal investigator · Centre Hospitalier Universitaire de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion